Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 3, 2003, Pages 192-195

  D'Angelo, Gennaro ^a   Lambiase, Alessandro ^b   Cortes, Magdalena ^b   Sgrulletta, Roberto ^b   Pasqualetti, Roberta ^c   Lamagna, Ambra ^a   Bonini, Stefano ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c Ospedale Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DRUG PRESERVATIVE; EYE DROPS; NONSTEROID ANTIINFLAMMATORY AGENT; PRESERVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORNEA INJURY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; OCULAR PRURITUS; PHOTOPHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANK SUM TEST; SCORING SYSTEM; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME; VERNAL CONJUNCTIVITIS; ALLERGIC CONJUNCTIVITIS; CLINICAL TRIAL; DRUG SCREENING; EVALUATION; PRESCHOOL CHILD; SAFETY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; CONJUNCTIVITIS, ALLERGIC; DICLOFENAC; DRUG EVALUATION; FEMALE; HUMANS; MALE; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; PROSPECTIVE STUDIES; SAFETY;

EID: 0038644528     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0612-6     Document Type: Article

References (23)

1. Abelson MB, Butrus S, Weston JH (1983) Aspirin therapy in vernal conjunctivitis. Am J Ophthalmol 95(4):502-505
2. Allansmith MR (1982) The eye and immunology. Mosby, St Louis, pp 118-124
3. Bhattacherjee P (1989) The role of arachidonate metabolites in ocular inflammation. In: The ocular effects of prostaglandins and other eicosanoids. Liss, New York, pp 211-227
4. Bielory L, Frohman LP (1992) Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 89:1-15
5. Bonini S, Bonini S, et al (1992) Conjunctiva hyperresponsiveness to ocular histamine challenge in patients with vernal conjunctivitis. J Allergy Clin Immunol 89(1, Pt 1): 103-107
6. Bonini S, Bonini S, Lambiase A, et al (2000) Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term follow-up. Ophthalmology 107(6):1157-1163
7. Buckley RJ (1988) Vernal keratoconjunctivitis. Int Ophthalmol Clin 28:303-308
8. Burstein NL (1980) Preservative cytotoxic threshold for benzalkonium chloride and chlohexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci 19(3):308-313
9. Burstein NL (1980) Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 25(1):15-30 review
10. Furer P, Berger J, Mayer JM, et al (2001) A comparative study of the ocular tolerance of 3 timolol based preparations: the influence of preservatives on ocular tolerance. J Fr Ophtalmol 24(1):13-19
11. Gilbard JP, et al (1989) Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation. Am J Ophthalmol 15; 107 (4):348-355
12. Hic J, et al (1984) Comparison of the anti-inflammatory effect of dexamethasone and diclofenac ophthalmic preparations. Klin Monatsbl Augenheilkd 184:494-498
13. Kana JS, et al (1984) Corticosteroid and the active ion transport of the isolated human lens. Ann Ophthalmol 16:1034-1039
14. Kaidman GW (1995) Diclofenac and its effect on corneal sensation. Arch Ophhalmol 113:262
15. Ku EC et al (1986) Effect of diclofenac sodium on the arachidonic acid cascade. Am J Med 80[Suppl 4b]:18-23
16. Lemp M, Zimmerman L (1988) Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Am J Ophthalmol 15;105(6): 607-613
17. Nathan H, Naveh N, Meyer E (1994) Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial of indomethacine. Doc Ophthalmol 85:247-257
18. Palmer RM, Kauffman HE (1995) Tear film pharmacology of eye drops, and toxicity. Curr Opin Ophthalmol 6(4):11-16
19. Schaefer K (1993) Conjunctivitis of allergic origin:immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 38[Suppl]:115-129
20. Spada CS, Woodward DF, Hawley SB, et al (1986) Leukotrienes cause eosinophil emigration into conjunctival tissue. Prostaglandins 31:795-809
21. Szerenyi K, Sorken K, et al (1994) Decrease in normal human corneal sensitivity with topical diclofenac sodium. Am J Ophthalmol 118:312-315
22. Tauber J, Abelson M, Ostrov C, et al (1994) A multicenter comparison of diclofenac sodium 0.1% to ketorolac tromethamine 0.5% in patients with acute seasonal allergic conjunctivitis. IOVS 35 (suppl): 1291
23. Van Husen H (1986) Topical treatment of anterior ocular disease with diclofenac Na eye drops. Klin Monatsbl Augenheilkd 188:615-619